Sphenopalatine Ganglion Block for Postdural Puncture Headache
Launched by SAKARYA UNIVERSITY · May 17, 2021
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-65 years-old
- • not having any headache diagnosis (G44 and subgroup according to the International Classification of Diseases-10 classification),
- • developed PDPH according to the International Headaches Classification after the neuraxial procedure
- Exclusion Criteria:
- • history of primary headaches such as migraine, cluster type, tension type
- • secondary headache such as preeclampsia / eclampsia, cerebral venous thrombosis, stroke, ruptured aneurysm, hypertensive encephalopathy, pituitary apoplexy, meningitis and subarachnoid hemorrhage
- • any local or systemic infection
About Sakarya University
Sakarya University is a distinguished academic institution dedicated to advancing scientific research and innovation in healthcare. With a robust commitment to improving patient outcomes, the university actively sponsors clinical trials that explore novel therapeutic approaches and contribute to evidence-based medicine. Leveraging a multidisciplinary team of researchers, clinicians, and scholars, Sakarya University fosters a collaborative environment aimed at enhancing clinical practices and addressing pressing health challenges. Through these initiatives, the university not only enriches the academic landscape but also plays a pivotal role in translating research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sakarya, , Turkey
Patients applied
Trial Officials
Burak Kaya, MD
Principal Investigator
Sakarya University
Serbülent Gökhan Beyaz, Prof MD
Study Chair
Istinye University
Ayça Taş Tuna, As Prof MD
Study Chair
Sakarya University
Havva Kocayiğit, MD
Study Chair
Sakarya University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials